Related references
Note: Only part of the references are listed.Inactivation of SMAD4 tumor suppressor gene during gastric carcinoma progression
Li-Hui Wang et al.
CLINICAL CANCER RESEARCH (2007)
ARDent about acetylation and deacetylation in hypoxia signalling
Rebecca Bilton et al.
TRENDS IN CELL BIOLOGY (2006)
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
David Z. Qian et al.
CANCER RESEARCH (2006)
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-α
DM Fath et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma:: importance of angiopoietin-2 and hypoxia-induced factor-1α
H Wada et al.
LIVER INTERNATIONAL (2006)
Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1α fragments in vitro
TA Murray-Rust et al.
FEBS LETTERS (2006)
Hepatocellular carcinoma cells containing hepatitis B virus X protein have enhanced invasive potential conditionally
DP Ou et al.
DIGESTIVE AND LIVER DISEASE (2006)
Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1α protein by recruiting histone deacetylase 1
YG Yoo et al.
EMBO JOURNAL (2006)
HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL
A Pathil et al.
HEPATOLOGY (2006)
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1α
XG Kong et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice
BK Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Effects of hepatitis B virus X protein on the development of liver cancer
XD Zhang et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2006)
Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells
DW Chan et al.
JOURNAL OF PATHOLOGY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Acetylation and deacetylation of non-histone proteins
MA Glozak et al.
GENE (2005)
HBV-induced carcinogenesis
Delphine Cougot et al.
JOURNAL OF CLINICAL VIROLOGY (2005)
Interaction between HIF-1α (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1α
T Arnesen et al.
FEBS LETTERS (2005)
Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)-1α and is not induced by hypoxia or HIF
R Bilton et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The HIF pathway in cancer
PH Maxwell
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
Analysis of ARD1 function in hypoxia response using retroviral RNA interference
TS Fisher et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells
MG Yeo et al.
MOLECULAR ENDOCRINOLOGY (2005)
Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3
FL Yu et al.
JOURNAL OF HEPATOLOGY (2005)
Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357
S Armeanu et al.
JOURNAL OF HEPATOLOGY (2005)
Signalling via the hypoxia-inducible factor-1 alpha requires multiple posttranslational mofications
C Brahimi-Horn et al.
CELLULAR SIGNALLING (2005)
Overexpression of metastatic tumor antigen in hepatocellular carcinoma:: Relationship to vascular invasion and estrogen receptor-α
WS Moon et al.
HUMAN PATHOLOGY (2004)
The carboxy-terminus of the hepatitis B virus X protein is necessary and sufficient for the activation of hypoxia-inducible factor-α
YG Yoo et al.
FEBS LETTERS (2004)
Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanism
TW Chung et al.
FASEB JOURNAL (2004)
Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1α through activation of mitogen-activated protein kinase pathway
YG Yoo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-α transactivation functions
SK Mishra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients
RS Herbst
SEMINARS IN ONCOLOGY (2003)
Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation
GL Nicolson et al.
CLINICAL & EXPERIMENTAL METASTASIS (2003)
The viral control of cellular acetylation signaling
C Caron et al.
BIOESSAYS (2003)
The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression
E Lara-Pezzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2002)
Regulation and destabilization of HIF-1α by ARD1-mediated acetylation
JW Jeong et al.
CELL (2002)
NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival
C Yun et al.
CANCER LETTERS (2002)
Hepatitis B virus X protein: a multifunctional viral regulator
S Murakami
JOURNAL OF GASTROENTEROLOGY (2001)
The hepatitis B virus HBx protein induces adherens junction disruption in a src-dependent manner
E Lara-Pezzi et al.
ONCOGENE (2001)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
Effect of the hepatitis B virus HBx protein on integrin-mediated adhesion to and migration on extracellular matrix
E Lara-Pezzi et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
